Serge H. Boyer

1.9k citations

28 papers · 1.2k indexed · h-index 18

Molecular Biology
Organic Chemistry top 5%
Epidemiology
Infectious Diseases top 10%
Endocrinology, Diabetes and Metabolism top 5%

Co-authors: Samuel J. Danishefsky Mark D. Erion Paul D. van Poelje K. Raja Reddy Steven H. Olson James M. Fujitaki Jorge Gomez‐Galeno Stephen A. Hitchcock
Topics: Carbohydrate Chemistry and Synthesis (7 papers)Microbial Natural Products and Biosynthesis (7 papers)Synthetic Organic Chemistry Methods (6 papers)
Cited by: Molecular Medicine Organic Chemistry Endocrinology, Diabetes and Metabolism
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Hepatology
Partner nations: United States Germany

In The Last Decade

Serge H. Boyer

28 papers receiving 1.1k citations

Peers

Countries citing papers authored by Serge H. Boyer

Since Specialization

Citations

This map shows the geographic impact of Serge H. Boyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge H. Boyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge H. Boyer more than expected).

Fields of papers citing papers by Serge H. Boyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serge H. Boyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge H. Boyer. The network helps show where Serge H. Boyer may publish in the future.

Co-authorship network of co-authors of Serge H. Boyer

This figure shows the co-authorship network connecting the top 25 collaborators of Serge H. Boyer. A scholar is included among the top collaborators of Serge H. Boyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge H. Boyer. Serge H. Boyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Scalable Synthesis of β-Lactamase Inhibitor QPX7728 by Sequential Nickel-Catalyzed Boron Insertion into a Benzofuran Substrate and Enantioselective Cyclopropanation of the Resulting Vinylboronate 2021 ·Organic Process Research & Development ·Serge H. Boyer,Ángela González-de-Castro,(unknown),Laurent Lefort,Zuolin Zhu,(unknown),(unknown),(unknown),André H. M. de Vries,Scott J. Hecker	17
2	Selection of QPX7831, an Orally Bioavailable Prodrug of Boronic Acid β-Lactamase Inhibitor QPX7728 2021 ·Journal of Medicinal Chemistry ·K. Raja Reddy,Jonathan Parkinson,Mojgan Sabet,Ziad Tarazi,Serge H. Boyer,Olga Lomovskaya,David C. Griffith,Scott J. Hecker,Michael N. Dudley	16
3	Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases 2020 ·Journal of Medicinal Chemistry ·Scott J. Hecker,K. Raja Reddy,Olga Lomovskaya,David C. Griffith,Debora Rubio-Aparicio,Kirk Nelson,Ruslan Tsivkovski,Dongxu Sun,Mojgan Sabet,Ziad Tarazi,Jonathan Parkinson,Maxim Totrov,Serge H. Boyer,Tomasz Glinka,O.A. Pemberton,Yu Chen,Michael N. Dudley	158
4	Scalable On-Demand Production of Purified Diazomethane Suitable for Sensitive Catalytic Reactions 2020 ·Organic Process Research & Development ·(unknown),(unknown),C. Breen,(unknown),Changfeng Huang,(unknown),Serge H. Boyer,Scott J. Hecker,Matthew M. Bio,Yuan‐Qing Fang,David D. Ford,M. Grace Russell	10
5	A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis 2010 ·ACS Medicinal Chemistry Letters ·Jorge Gomez‐Galeno,Qun Dang,(unknown),Serge H. Boyer,(unknown),Zhili Sun,Mingwei Chen,(unknown),Paul D. van Poelje,Deidre A. MacKenna,Edward E. Cable,(unknown),Patricia D. Finn,(unknown),David L. Linemeyer,Scott J. Hecker,Mark D. Erion	75
6	Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma 2009 ·Cancer Chemotherapy and Pharmacology ·Deidre A. MacKenna,Annika C. Montag,Serge H. Boyer,David L. Linemeyer,Mark D. Erion	6
7	Pradefovir: A Prodrug That Targets Adefovir to the Liver for the Treatment of Hepatitis B 2008 ·Journal of Medicinal Chemistry ·K. Raja Reddy,Michael C. Matelich,Bheemarao G. Ugarkar,Jorge Gomez‐Galeno,(unknown),(unknown),Zhili Sun,(unknown),Timothy J. Colby,James M. Fujitaki,Serge H. Boyer,Paul D. van Poelje,Mark D. Erion	55
8	Synthesis and Biological Evaluation of a Series of Liver-Selective Phosphonic Acid Thyroid Hormone Receptor Agonists and Their Prodrugs 2008 ·Journal of Medicinal Chemistry ·Serge H. Boyer,Hongjian Jiang,Jason Jacintho,Mali V. Reddy,Haiqing Li,Wenyu Li,(unknown),WILLIAM G. SCHULZ,Edward E. Cable,Jinzhao Hou,Rongrong Wu,James M. Fujitaki,Scott J. Hecker,Mark D. Erion	45
9	Liver-Targeted Prodrugs of 2‘-C-Methyladenosine for Therapy of Hepatitis C Virus Infection 2007 ·Journal of Medicinal Chemistry ·Scott J. Hecker,K. Raja Reddy,Paul D. van Poelje,Zhili Sun,Wenjian Huang,(unknown),M. Venkat Ram Reddy,James M. Fujitaki,David B. Olsen,Kenneth A. Koeplinger,Serge H. Boyer,David L. Linemeyer,Malcolm MacCoss,Mark D. Erion	29
10	Synthesis and Characterization of a Novel Liver-Targeted Prodrug of Cytosine-1-β-d-arabinofuranoside Monophosphate for the Treatment of Hepatocellular Carcinoma 2006 ·Journal of Medicinal Chemistry ·Serge H. Boyer,Zhili Sun,Hongjian Jiang,(unknown),Jorge Gomez‐Galeno,(unknown),K. Raja Reddy,Bheemarao G. Ugarkar,Deidre A. MacKenna,Mark D. Erion	37
11	Adenosine Kinase Inhibitors. 5. Synthesis, Enzyme Inhibition, and Analgesic Activity of Diaryl-erythro-furanosyltubercidin Analogues 2005 ·Journal of Medicinal Chemistry ·Serge H. Boyer,Bheemarao G. Ugarkar,(unknown),(unknown),Michael C. Matelich,(unknown),Jorge Gomez‐Galeno,Rohan Mendonca,Megumi Tsuchiya,Atsushi Nagahisa,(unknown),James B. Wiesner,Mark D. Erion	32
12	Stereoselective synthesis of 4-C-methyl-2,3,5-tri-O-benzyl-d-ribofuranose and 4-C-methyl-2,3,5-tri-O-benzyl-l-lyxofuranose 2003 ·Tetrahedron Letters ·Serge H. Boyer,Bheemarao G. Ugarkar,Mark D. Erion	1
13	Interaction of calicheamicin γ ₁ ^I and its related carbohydrates with DNA–protein complexes 1999 ·Proceedings of the National Academy of Sciences ·Claudia Sissi,Jayshree Aiyar,Serge H. Boyer,(unknown),Samuel J. Danishefsky,Donald M. Crothers	14
14	Synthese und DNA‐Bindungseigenschaften von Hybriden aus der Kohlenhydrat‐Einheit von Calicheamicin γ₁^I und den Aglycon von Daunorubicin: Calichearubicine A und B 1996 ·Angewandte Chemie ·Kristopher M. Depew,(unknown),Serge H. Boyer,Derek J. Denhart,Norihiro Ikemoto,Samuel J. Danishefsky,Donald M. Crothers	9
15	Studies Related to the Carbohydrate Sectors of Esperamicin and Calicheamicin: Definition of the Stability Limits of the Esperamicin Domain and Fashioning of a Glycosyl Donor from the Calicheamicin Domain 1995 ·Journal of the American Chemical Society ·Randall L. Halcomb,Serge H. Boyer,Mark D. Wittman,Steven H. Olson,Derek J. Denhart,Kevin K.‐C. Liu,Samuel J. Danishefsky	49
16	A Remarkable Glycosidation Reaction: The Total Synthesis of Calicheamicin .gamma.1I 1995 ·Journal of the American Chemical Society ·Stephen A. Hitchcock,Margaret Y. Chu‐Moyer,Serge H. Boyer,Steven H. Olson,Samuel J. Danishefsky	50
17	ChemInform Abstract: A Convergent Total Synthesis of Calicheamicin γI 1. 1994 ·ChemInform ·Stephen A. Hitchcock,Serge H. Boyer,Margaret Y. Chu‐Moyer,Steven H. Olson,Samuel J. Danishefsky	1
18	Eine konvergente Totalsynthese von Calicheamicin γ^I₁ 1994 ·Angewandte Chemie ·Stephen A. Hitchcock,Serge H. Boyer,Margaret Y. Chu‐Moyer,Steven H. Olson,Samuel J. Danishefsky	21
19	Synthesis of the Calicheamicin Aryltetrasaccharide Domain Bearing a Reducing Terminus: Coupling of Fully Synthetic Aglycone and Carbohydrate Domains by the Schmidt Reaction 1992 ·Angewandte Chemie International Edition in English ·Randall L. Halcomb,Serge H. Boyer,Samuel J. Danishefsky	35
20	Hepatic biochemical changes as a result of acute cocaine administration in the mouse 1991 ·Hepatology ·Serge H. Boyer,Dennis R. Petersen	27

About Serge H. Boyer

Serge H. Boyer is a scholar working on Physiology, Pharmacology and Organic Chemistry, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include Carbohydrate Chemistry and Synthesis (7 papers), Microbial Natural Products and Biosynthesis (7 papers) and Synthetic Organic Chemistry Methods (6 papers). The work is most often cited by research in Molecular Medicine (125 citations), Organic Chemistry (424 citations) and Endocrinology, Diabetes and Metabolism (202 citations). Serge H. Boyer has collaborated with scholars based in United States and Germany. Frequent co-authors include Samuel J. Danishefsky, Mark D. Erion, Paul D. van Poelje, K. Raja Reddy, Steven H. Olson, James M. Fujitaki, Jorge Gomez‐Galeno, Stephen A. Hitchcock, David L. Linemeyer and Scott J. Hecker. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact